-
Mashup Score: 22
FDA is in a quandary about compounding of the new obesity drugs, semaglutide and tirzepatide. The nominee to lead FDA has an interest.
Source: conscienhealth.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3
Unconstrained egos with simple answers for diet and health are having a moment. They will serve themselves first and public health last.
Source: conscienhealth.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 11
ObesityWeek 2024 in San Antonio offers many insights for consolidating our knowledge of this disease. Here are five things to seek out.
Source: conscienhealth.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 11Metabolic Surgery: Up, Down, or Sideways? - ConscienHealth - 1 month(s) ago
Will metabolic surgery go up, down, or sideways as obesity care gains wider acceptance? We see a strong case for long-term growth.
Source: conscienhealth.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 10
In a recent analysis, researchers found a signal that semaglutide might lower the risk of opioid overdoses by as much as two-thirds.
Source: conscienhealth.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5
Since forever, health systems have been closed to the need for obesity care. So it’s hardly surprising that people seek it elsewhere.
Source: conscienhealth.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7
New NHANES data on obesity prevalence is out today, suggesting the dynamics are changing. Overall rates are stable, severe obesity is rising.
Source: conscienhealth.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7
Senior Research Fellow Saul Justin Newman won an Ig Nobel Prize this year by debunking the concept of blue zone diets.
Source: conscienhealth.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 8
Better obesity treatment options have people buying new clothes and better food, spending less on weight watching and more on health.
Source: conscienhealth.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 13
The news that tirzepatide is 94% effective for diabetes prevention in persons with prediabetes and overweight or obesity is impressive.
Source: conscienhealth.orgCategories: General Medicine News, General HCPsTweet
For reference: https://t.co/LBwpy8c01U